期刊文献+

Bax channel blocker逆转衰老骨髓间充质干细胞生物学行为的研究 被引量:1

Bax channel blocker reverses the biological characteristics of aged bone marrow stromal cells
下载PDF
导出
摘要 目的:探讨Bax channel blocker(BCB)对自然衰老大鼠骨髓间充质干细胞(aged-BMSCs)生物学功能的影响。方法:全骨髓贴壁培养法获得22月龄(老年)和2周龄(年青)大鼠BMSCs,β-gal染色鉴定aged-BMSCs,用BCB对实验组细胞进行干预,以Nanog和Oct-4为靶标,RT-PCR筛选最佳作用浓度。使用RT-PCR和Western Blot分别检测细胞衰老水平及成骨分化的关键基因及蛋白的表达;对细胞药物干预同时进行成骨分化诱导,培养14 d后进行碱性磷酸酶(ALP)染色,21 d后茜素红染色。结果:BCB对aged-BMSCs最佳实验浓度为10μmol/L。BCB能明显降低aged-BMSCs细胞内β-gal含量,在mRNA水平和蛋白水平降低衰老相关基因p53和p21WAF1/cip1表达;明显提升干细胞标记物Nanog、Oct-4。成骨分化诱导后,成骨分化标志基因表达上调,ALP和茜素红染色水平提升。结论:BCB能够逆转aged-BMSCs的衰老,促进其骨向分化。 Objective: To investigate the effects of Bax channel blocker(BCB) on the biological characteristics of aged bone marrow stromal cells (aged-BMSCs). Methods: BMSCs from 22 month old (aged) and 2 week old rats (young) were obtained by whole bone marrow adherent culture and identified by β-gal staining. The optimal dose of BCB for the detection of Nanog and Oct-4 expression was determined by Real Time PCR. Then the senescence-associated characteristics at cellular and molecular levels and osteogenic ability were tested by RT-PCR and Western Blot. Osteogenic induction and BCB intervention were proceeded. ALP staining and Alizarin Red staining were conducted to observe the osteogenic potential of the ceils. Results: BCB at 10 ttmol/L( optional dose) declined β-gal expression in aged-BMSCs, decreased the expression of p53 and p21^WAF1/cipl at mRNA and protein levels, and promoted the expression of Nanog and Oct-4, promoted the expression of osteogenesis-associated genes, increased ALP and Alizarin Red staining levels. Conclusion: BCB can reverse the biological characteristics of aged-BMSCs in vitro and promote the osteogenesis potential.
出处 《实用口腔医学杂志》 CAS CSCD 北大核心 2014年第3期311-316,共6页 Journal of Practical Stomatology
基金 全军医学科研"十二五"计划(编号:AWS11J012-07)
关键词 BAX channel blocker(BCB) 衰老 成骨分化 骨髓间充质干细胞 Bax channel blocker(BCB) Aging Osteogenesis differentiation BMSC
  • 相关文献

参考文献20

  • 1Jiang Y,Jahagirdar BN,Reinhardt RL,et al.Pluripotency of mesenchymal stem cells derived from adult marrow [J].Nature,2002,418(6893):41-49.
  • 2Reya T,Morrison S J,Clarke MF,et al.Stem cells,canc-er,and cancer stem cells [J].Nature,2001,414(6859):105-111.
  • 3Bergfeld SA,DeClerck YA.Bone marrow-derived mesen-chymal stem cells and the tumor microenvironment [J].Cancer Metastasis Rev,2010,29(2):249-261.
  • 4Tu Q,Valverde P,Chen J.Osterix enhances proliferation and osteogenic potential of bone marrow stromal cells [J].Biochem Biophys Res Commun,2006,341(4):1257-1265.
  • 5Friedenstein AJ,Piatetzky-Shapiro II,Petrakova KV.Osteo-genesis in transplants of bone marrow cells [J].J EmbryolExp Morphol,1966,16(3):381-390.
  • 6Horwitz EM,Prockop D J,Fitzpatrick LA,et al.Transplant-ability and therapeutic effects of bone marrow-derived mes-enchymal cells in children with osteogenesis imperfecta [J].Nat Med,1999,5(3):309-313.
  • 7Pittenger MF,Mackay AM,Beck SC,et al.Muhilineage po-tential of adult human mesenchymal stem cells [J].Science,1999,284(5411):143-147.
  • 8Zhou S,Greenberger JS,Epperly MW,et al.Age-related in-trinsic changes in human bone-marrow-derived mesenchymal stem cells and their differentiation to osteoblasts [J].Aging Cell,2008,7(3):335-343.
  • 9Pignolo R J,Suda RK,McMillan EA,et al.Defects in te-lomere maintenance molecules impair osteoblast differentia-tion and promote osteoporosis[J].Aging Cell,2008,7(1):23-31.
  • 10Huang Z,Ren PG,Ma T,et al.Modulating osteogenesis of mesenchymal stem cells by modifying growth factor availabil-ity[J].Cytokine,2010,51(3):305-310.

同被引文献1

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部